Asif Javed

Asif Javed

Auto-generated profile, based on publicly available information

Asif Javed

School of Biomedical Sciences, LKS Faculty of Medicine, the University of Hong Kong, Hong Kong Special Administrative Region, China

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2019 in Genetics in Medicine
Verified
Journal Article
Open access
PDF file
LWLloyd B. Williams
Lloyd B. Williams
AJAsif Javed
Asif Javed
ASAmin Sabri
Amin Sabri
DMDenise J. Morgan
Denise J. Morgan
CHChad D. Huff
Chad D. Huff
Margaret DeAngelisMargaret DeAngelis
Margaret DeAngelis
Purpose To identify the molecular cause in five unrelated families with a distinct autosomal dominant ocular systemic disorder we called ROSAH syndrome due to clinical features of retinal dystrophy, optic nerve edema, splenomegaly, anhidrosis, and migraine headache. Methods Independent discovery exome and genome sequencing in families 1, 2, and 3, and confirmation in families 4 and 5. Expression of wild-type messenger RNA and protein in human and mouse tissues and cell lines. Ciliary assays in fibroblasts from affected and unaffected family members. Results We found the heterozygous missense variant in the ɑ-kinase gene, ALPK1, (c.710C>T, [p.Thr237Met]), segregated with disease in all five families. All patients shared the ROSAH phenotype with additional low-grade ocular inflammation, pancytopenia, recurrent infections, and mild renal impairment in some. ALPK1 was notably expressed in retina, retinal pigment epithelium, and optic nerve, with immunofluorescence indicating localization to the basal body of the connecting cilium of the photoreceptors, and presence in the sweat glands. Immunocytofluorescence revealed expression at the centrioles and spindle poles during metaphase, and at the base of the primary cilium. Affected family member fibroblasts demonstrated defective ciliogenesis. Conclusion Heterozygosity for ALPK1, p.Thr237Met leads to ROSAH syndrome, an autosomal dominant ocular systemic disorder.

25 June 2020 in Blood
Verified
Journal Article
Closed access
PDF file
TKTun Kiat Ko
Tun Kiat Ko
AJAsif Javed
Asif Javed
KLKian Leong Lee
Kian Leong Lee
TPThushangi N. Pathiraja
Thushangi N. Pathiraja
XLXingliang Liu
Xingliang Liu
SOS. Tiong Ong
S. Tiong Ong
Targeted therapies against the BCR-ABL1 kinase have revolutionized treatment of chronic phase (CP) chronic myeloid leukemia (CML). In contrast, management of blast crisis (BC) CML remains challenging because BC cells acquire complex molecular alterations that confer stemness features to progenitor populations, and resistance to BCR-ABL1 tyrosine kinase inhibitors. Comprehensive models of BC transformation have proved elusive due to the rarity and genetic heterogeneity of BC, but are important for developing biomarkers predicting BC progression and effective therapies. To better understand BC, we performed an integrated multi-'omics' analysis of 74 CP and BC samples using whole genome and exome sequencing, transcriptome and methylome profiling, and chromatin immunoprecipitation followed by high-throughput sequencing. Employing pathway-based analysis, we found the BC genome was significantly enriched for mutations affecting components of the polycomb repressive complex (PRC) pathway. While transcriptomically, BC progenitors were enriched and depleted for PRC1- and PRC2-related gene sets respectively. By integrating our datasets, we determined that BC progenitors undergo PRC-driven epigenetic reprogramming toward a convergent transcriptomic state. Specifically, PRC2 directs BC DNA hypermethylation, which in turn silences key genes involved in myeloid differentiation and tumor suppressor function via so-called 'epigenetic switching', while PRC1 represses an overlapping and distinct set of genes, including novel BC tumor suppressors. Based on these observations, we developed an integrated model of BC that facilitated the identification of combinatorial therapies capable of reversing BC reprogramming (decitabine+PRC1 inhibitors), novel PRC-silenced tumor suppressor genes (NR4A2), and gene expression signatures predictive of disease progression and drug resistance in CP.

1 January 2006
Verified
Conference Paper
Closed access
PDP. Drineas
P. Drineas
AJA. Javed
A. Javed
MMM. Magdon-Ismail
M. Magdon-Ismail
GPG. Pandurangant
G. Pandurangant
RVR. Virrankoski
R. Virrankoski
ASA. Savvides
A. Savvides
This paper focuses on the principled study of distance reconstruction for distance-based node localization. We address an important issue in node localization by showing that a highly incomplete set of inter-node distance measurements obtained in ad-hoc node deployments carries sufficient information for the accurate reconstruction of the missing distances, even in the presence of noise and sensor node failures. We provide an efficient and provably accurate algorithm for this reconstruction, and we show that the resulting error is bounded, decreasing at a rate that is inversely proportional to radicn, the square root of the number of nodes in the region of deployment. Although this result is applicable to many localization schemes, in this paper we illustrate its use in conjunction with the popular multidimensional scaling algorithm. Our analysis reveals valuable insights and key factors to consider during the sensor network setup phase, to improve the quality of the position estimates

12 March 2023 in Neuromuscular Disorders
Verified
Journal Article
Open access
AKAnna Ky Kwong
Anna Ky Kwong
YZYanmin Zhang
Yanmin Zhang
RHRonnie Sl Ho
Ronnie Sl Ho
YGYuan Gao
Yuan Gao
XLXu Ling
Xu Ling
SCSophelia Hoi Shan Chan
Sophelia Hoi Shan Chan
Collagen VI-related myopathies are a group of disorders that cause muscle weakness and joint contractures with significant variability in disease severity among patients. Here we report the clinical and genetic characteristics of 13 Chinese patients. Detailed histological, radiological and muscle transcriptomic evaluations were also conducted for selected representative patients. Across the cohort, fifteen putative disease causal variants were identified in three genes encoding collagen VI subunits, COL6A1 (n=6), COL6A2 (n=5), and COL6A3 (n=4). Most of these variants (12/15, 80%) were dominant negative and occurred at the triple helical domain. The rest (3/15, 20%) were located at the C-terminus. Two previously unreported variants, an in-frame mutation (COL6A1:c.1084_1092del) and a missense mutation (COL6A2:c.811G>C), were also noted. The transcriptome data from the muscle biopsies of two patients in the study with dominant negative mutations [COL6A2:c.811G>C and COL6A1:c.930+189C>T] supports the accepted aetiology of Collagen VI myopathy as dysfunction of the extracellular matrix. It also suggests there are perturbations to skeletal muscle differentiation and skeletal system development. It should be noted that although the phenotypes of patients can be mostly explained by the position and dominant-negative effect of the variants, exceptions and variability still exist and have to be reckoned with. This study provides valuable data explaining the varying severity of phenotypes among ethnically Chinese patients.

19 October 2020 in Blood Cancer Journal
Verified
Journal Article
Open access
PDF file
STSze P. Tsui
Sze P. Tsui
HIHo W. Ip
Ho W. Ip
NSNicole Y. Saw
Nicole Y. Saw
CZChunxiao Zhang
Chunxiao Zhang
ACArthur K. Cheung
Arthur K. Cheung
ALAnskar Yu Hung Leung
Anskar Yu Hung Leung

16 December 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
HFHaifeng Fu
Haifeng Fu
CCChunxiao Chen
Chunxiao Chen
YHYunying Huang
Yunying Huang
WZWeiyu Zhang
Weiyu Zhang
SLShilong Li
Shilong Li
PLPentao Liu
Pentao Liu
N6-methyladenosine (m6A) is the most prevalent RNA modification and plays diverse roles in mammalian cells. However, its significance in human trophoblast lineage commitment and placenta development remains poorly understood. Here we show that METTL3, the primary enzyme responsible for m6A depositions, specifically marks cytotrophoblasts in human placenta, and exhibits defective expression in cytotrophoblasts from preeclampsia patients. Through in-depth in vitro investigation, we identify critical roles of METTL3 in generating human trophoblast stem cells (hTSCs) from human expanded potential stem cells, and in maintaining hTSCs’ self-renewal and identity. In hTSCs, METTL3 loss induces pro-inflammatory responses and promotes premature senescence, leading to preeclampsia-associated transcriptomic signature. Mechanistically, METTL3-dependent m6A methylation directly regulates histone modifiers such as EP300 and EZH2 to maintain epigenetic homeostasis, as well as various transcription factors, including JUND. Targeted inhibition of EP300 in hTSCs successfully ameliorate preeclampsia signature caused by METTL3 deficiency. These findings reveal METTL3-dependent m6A methylation as a critical regulator of human trophoblast development and its potential involvement in pregnancy-related diseases.